New Jersey Neuroscience Institute / The University of Texas Health Science Center / University of Illinois Hospital / Memorial Hermann Hospital / Presbyterian Hospital / Memorial Sloan Kettering Cancer Center / University of California San Diego Moores Cancer Center / Beth Israel Deaconess Medical Center / Columbia University Medical Center / Mischer Neuroscience Institute / /
IndustryTerm
non-invasive medical device / platform technology / /
MedicalCondition
tumor / U.S. The disease / mild-to-moderate rash / cancer / histologically-confirmed glioblastoma multiforme / disease / solid tumors / primary brain tumor / Recurrent Glioblastoma Multiforme / recurrent glioblastoma brain tumors / several noted brain cancer / brain tumor / slow and reverse tumor / /
University of Texas Health Science Center / Houston / Presbyterian Hospital / Food and Drug Administration / University of Illinois Hospital in Chicago / Columbia University Medical Center / Memorial Hermann Hospital / Memorial Sloan Kettering Cancer Center / Beth Israel Deaconess Medical Center in Boston / University of California San Diego Moores Cancer Center / Mischer Neuroscience Institute / New Jersey Neuroscience Institute / of California San Diego Moores Cancer Center / /
Person
Andrew Lassman / Eric T. Wong / Lisa DeAngelis / Gabriel Leung / Herbert Engelhard / Frank Leonard / Jay-Jiguang Zhu / Joseph Landolfi / Beth Israel / / /
Novocure™ Establishes Initial Clinical Centers of Excellence for Treatment of Recurrent Glioblastoma Multiforme with Tumor Treating Fields (TTFields)™ Therapy Four clinical sites in the U.S. have completed required t